학술논문
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
Document Type
Article
Author
Rothenberg, M.E.; Roufosse, F.; Faguer, S.; Gleich, G.J.; Steinfeld, J.; Yancey, S.W.; Mavropoulou, E.; Kwon, N.; García, G.R.; Sosso, A.; Wehbe, L.; Yañez, A.; Blockmans, D.; Antila, M.A.; Blanco, D.; Grava, S.; Lima, M.A.; Francisco Pez, A.L.; Hamidou, M.A.; Kahn, J.-E.; Lefévre, G.; Brockow, K.; Kern, P.M.; Reiter, A.J.; Walz, B.; Welte, T.; Pane, F.; Vannucchi, A.M.; Cerino-Javier, R.; Gazca-Aguilar, A.; Hernández-Colín, D.D.; Valdéz-López, H.G.; Kupryś-Lipińska, I.R.; Musial, J.; Prejzner, W.; Mihaly, E.; Popov, V.; Zdrenghea, M.T.; Gritsaev, S.V.; Ivanov, V.; Tsyba, N.; Alonso, A.; Cid Xutgla, M.C.; Fox, M.L.; Delgado, R.G.; Hernández Rivas, J.M.; Santillana, G.S.; González, A.I.; Wardlaw, A.J.; Akuthota, P.; Butterfield, J.H.; Chupp, G.L.; Cox, J.B.; Jhaveri, D.
Source
In: Journal of Allergy and Clinical Immunology: In Practice . (Journal of Allergy and Clinical Immunology: In Practice, September 2022, 10(9):2367-2374.e3)
Subject
Language
English
ISSN
22132198